Carvedilol Phosphate
- Product NDC
- 42291-481
- 11-digit product format
- 422910481
- Labeler code
- 42291
- Product ID
- 42291-481_4a7c3ea5-24e9-8ace-e063-6294a90a879d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carvedilol Phosphate
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA204717
- Marketing category
- ANDA
- Marketing start
- 2024-06-27
- Substance
- CARVEDILOL PHOSPHATE
- Active strength
- 40 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], Adrenergic beta1-Antagonists [MoA], Adrenergic beta2-Antagonists [MoA], alpha-Adrenergic Blocker [EPC], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Carvedilol Phosphate
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CARVEDILOL PHOSPHATE | 40 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | EQT531S367 |
| Rxcui | 860510, 860516, 860522, 860532 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 42291-481-30 | Carvedilol Phosphate | 30 in 1 BOTTLE | CAPSULE, EXTENDED RELEASE | 30 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 42291-481 | CARVEDILOL PHOSPHATE CAPSULE, EXTENDED RELEASE [AVKARE] | 1 | Current NDC, 1 package rows | 20240629_1be1b5d2-eb2c-1d02-e063-6294a90adbba.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 42291-481-30 | 42291048130 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-481-30) | 2024-06-27 | No | No | Current |